US equities |
MU $1,055.05 ▲+0.91% NVDA $237.92 ▼-0.55% SNDK $1,695.76 ▲+2.13% AMD $640.10 ▼-1.44% INTC $114.31 ▲+1.61% SPCX $168.42 ▼-2.04% TSLA $375.64 ▼-1.32% MRVL $284.21 ▼-0.98%
FinancialContent

Seres Therapeutics, Inc. - Common Stock (NQ:MCRB)

2.910 +0.010 (+0.34%)
Delayed Quote Updated: 10:10 AM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Seres Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Earnings Scheduled For May 4, 2021 ↗
Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million. •... 
Via Benzinga
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
News headline image
Seres Therapeutics to Host First Quarter 2021 Financial Results and Operational Progress Conference Call and Webcast on May 4, 2021
From Seres Therapeutics, Inc.
Via Business Wire
News headline image
Seres Therapeutics to Present at Jefferies Microbiome-Based Therapeutics Summit
From Seres Therapeutics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >